AngioDynamics, Inc. (ANGO) key performance indicators and operating metrics (32 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| AlphaVac revenue | 4.4M | FY2026-Q3 |
| Med Device YoY Revenue Growth | 1.10 percent | FY2026-Q3 |
| Med Tech YoY Revenue Growth | 19.00 percent | FY2026-Q3 |
| YoY Revenue Growth | 8.90 percent | FY2026-Q3 |
| Med Device segment sales | 41.1M | FY2026-Q3 |
| Med Tech segment sales | 37.3M | FY2026-Q3 |
| Auryon Sales | 16.3M | FY2026-Q3 |
| Total NanoKnife Sales (Including Capital) | 7.6M | FY2026-Q3 |
| Adjusted Loss per Share | -0.07 USD_per_share | FY2026-Q3 |
| GAAP Loss Per Share | -0.19 USD_per_share | FY2026-Q3 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 1.8M | FY2026-Q3 |
| Cash | 37.8M | FY2026-Q3 |
| NanoKnife Total YoY Growth | 21.00 percent | FY2026-Q3 |
| Adjusted Net Loss | -3M | FY2026-Q3 |
Back to ANGO overview · ANGO earnings · ANGO holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.